CSIMarket
 


Immunic Inc   (IMUX)
Other Ticker:  
 

Immunic Inc 's Leverage Ratio

IMUX's quarterly Leverage Ratio and Total Liabilities, Equity growth




IMUX Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -25.2 % 5.89 % 0.37 % -19.95 % -10.69 %
Y / Y Total Liabilities Change 8.71 % -28.2 % -29.95 % 35.77 % 31.89 %
Leverage Ratio MRQ 0.11 0.08 0.08 0.09 0.07
Overall Ranking # # # # #
Seq. Equity Change -14.89 % -7.33 % 8.53 % -12.61 % 20.48 %
Seq. Total Liabilities Change 10.69 % -9.21 % 0.49 % 7.65 % -26.89 %



Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 10.69%, Leverage Ratio detoriated to 0.11, above company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry Immunic Inc achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are IMUX Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Immunic Inc 's Equity $ 109 Millions Visit IMUX's Balance sheet
Immunic Inc 's Total Liabilities $ 12 Millions Visit IMUX's Balance sheet
Source of IMUX's Sales Visit IMUX's Sales by Geography


Cumulative Immunic Inc 's Leverage Ratio

IMUX's Leverage Ratio for the trailling 12 Months

IMUX Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -25.2 % 5.89 % 0.37 % -19.95 % -10.69 %
Y / Y Total Liabilities TTM Growth 8.71 % -28.2 % -29.95 % 35.77 % 31.89 %
Leverage Ratio TTM 0.09 0.08 0.09 0.1 0.09
Total Ranking TTM # 179 # 220 # 245 # 47 # 78
Seq. Equity TTM Growth -14.89 % -7.33 % 8.53 % -12.61 % 20.48 %
Seq. Total Liabilities TTM Growth 10.69 % -9.21 % 0.49 % 7.65 % -26.89 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 10.69%, Leverage Ratio improved to 0.09, below Immunic Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 74 other companies have achieved lower Leverage Ratio than Immunic Inc . While total ranking remained unchanged compare to previous quarter at no. 179.

Explain Leverage Ratio?
Who are IMUX Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 108
Within the Market # 179


TTM Leverage Ratio Statistics
High Average Low
0.12 0.1 0.07
(Jun 30 2019)   (Dec 31 2020)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity
Salarius Pharmaceuticals inc   0.29 $ 4.827  Millions$ 16.613  Millions
Pulmatrix Inc   0.29 $ 10.123  Millions$ 35.046  Millions
Histogen Inc   0.29 $ 4.682  Millions$ 16.254  Millions
Ligand Pharmaceuticals Incorporated  0.29 $ 234.307  Millions$ 816.298  Millions
Centessa Pharmaceuticals Plc  0.29 $ 106.434  Millions$ 372.921  Millions
Prometheus Biosciences Inc   0.28 $ 66.083  Millions$ 232.535  Millions
Concert Pharmaceuticals Inc   0.28 $ 37.862  Millions$ 133.272  Millions
Vertex Pharmaceuticals Inc  0.28 $ 3,676.800  Millions$ 13,029.600  Millions
Protokinetix Incorporated  0.28 $ 0.105  Millions$ 0.375  Millions
Iveric Bio Inc   0.28 $ 72.264  Millions$ 259.526  Millions
Kempharm Inc  0.27 $ 25.757  Millions$ 93.794  Millions
Neurobo Pharmaceuticals Inc   0.27 $ 1.619  Millions$ 5.938  Millions
Renovorx Inc   0.27 $ 2.204  Millions$ 8.148  Millions
23andme Holding Co   0.27 $ 221.412  Millions$ 819.320  Millions
Savara Inc   0.27 $ 31.244  Millions$ 116.514  Millions
Nkarta Inc   0.26 $ 104.535  Millions$ 399.264  Millions
Amylyx Pharmaceuticals Inc   0.26 $ 37.415  Millions$ 144.028  Millions
Lianbio  0.26 $ 79.018  Millions$ 306.598  Millions
Hookipa Pharma inc   0.26 $ 28.909  Millions$ 113.348  Millions
United Therapeutics Corporation  0.25 $ 1,159.300  Millions$ 4,562.200  Millions
Thorne Healthtech Inc   0.25 $ 32.963  Millions$ 131.923  Millions
Akouos inc   0.25 $ 44.671  Millions$ 180.838  Millions
Lftd Partners Inc   0.25 $ 8.365  Millions$ 33.934  Millions
Corvus Pharmaceuticals Inc   0.24 $ 15.667  Millions$ 64.681  Millions
Abcellera Biologics Inc   0.24 $ 302.237  Millions$ 1,250.172  Millions
Schrodinger Inc   0.24 $ 111.710  Millions$ 463.122  Millions
Longeveron Inc   0.24 $ 5.900  Millions$ 24.615  Millions
Benitec Biopharma Inc   0.24 $ 3.502  Millions$ 14.613  Millions
Zentalis Pharmaceuticals Inc   0.23 $ 100.689  Millions$ 428.738  Millions
Catalyst Pharmaceuticals Inc   0.23 $ 63.073  Millions$ 270.041  Millions

Date modified: 2022-11-06T02:34:00+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OCX's Profile

Stock Price

OCX's Financials

Business Description

Fundamentals

Charts & Quotes

OCX's News

Suppliers

OCX's Competitors

Customers & Markets

Economic Indicators

OCX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071